When it comes to tackling chronic disease, the United States is lagging behind its peers. A new study published in The Lancet reveals that among 25 high-income Western countries, the US has shown the slowest progress in reducing deaths from noncommunicable diseases such as cancer, heart disease, stroke, and diabetes.

The research, led by Imperial College London, analyzed mortality data from 185 countries between 2010 and 2019. While most nations reported overall declines in the probability of dying before age 80 from chronic disease, the US not only saw smaller reductions compared with other wealthy countries but also a troubling rise in deaths among younger adults aged 20 to 45.

The data show that between 2010 and 2019, deaths from chronic disease decreased in most US age groups but increased among young adults, a rare and alarming trend for a high-income country. Researchers describe this as “a rare phenomenon in high-income Western countries,” suggesting that the problem is systemic, not just demographic.

Majid Ezzati, the study’s senior author and professor of global health at Imperial, explained that while older Americans benefited from improved treatments and detection for heart disease and cancer, younger generations faced new and worsening risks including obesity, alcohol use disorders, and neuropsychiatric conditions like dementia.

The global picture provides a stark contrast. Roughly 80 percent of countries saw reductions in chronic disease mortality during the past decade, covering more than 70 percent of the world’s population. Denmark led the high-income group with the steepest decline, followed closely by Norway and Finland. Germany performed poorly as well, showing only slightly better results than the US.

While all high-income countries experienced a slowdown in the rate of decline compared to earlier decades, the United States stood out for its stagnation in working-age adults and actual increases in younger adults. Other countries managed to balance slower declines in older age groups with sharper improvements in working-age populations, but the US did not.

Why Is the US Falling Behind in Mortality?

The study did not dive into root causes, but experts point to a combination of health system and social factors:

Healthcare access and disparities: Millions of Americans lack consistent primary care, delaying diagnosis and treatment of chronic conditions. Without a physician close to home, routine screenings often fall through the cracks.

Social determinants of health: Income inequality, food insecurity, and limited access to healthy lifestyles all disproportionately affect younger and working-age adults.

Rise in neuropsychiatric conditions: While cancer and heart disease deaths declined, increases in dementia, alcohol use disorders, and mental health-related conditions offset gains.

Obesity and lifestyle factors: Rising rates of obesity, poor diets, and sedentary behavior have made chronic diseases harder to control, particularly among younger people.

Ezzati emphasized that underinvestment in public health is a common denominator. “In both the US and Germany, there are segments of the population in which there has been less investment in public health, and these disparities in investment can lead to broad barriers to accessing care,” he said.

Is This A Global Slowdown, Not Just an American Problem?

The US may be the slowest among wealthy nations, but it is not alone in struggling. Nearly two-thirds of all countries saw slower progress in reducing chronic disease mortality during 2010–2019 compared with the previous decade.

In northern Europe, for example, Denmark and Finland reported slower improvements among older adults, but these were offset by faster progress among working-age adults. That balance prevented them from stagnating as the US did.

Globally, the slowdown raises concerns about whether countries will meet the UN Sustainable Development Goal of reducing premature mortality from noncommunicable diseases by one-third by 2030.

So what sets top performers like Denmark apart? Researchers credit strong investment in preventive health, early detection, and broad access to primary care. Comprehensive strategies for cardiovascular disease prevention, aggressive anti-smoking campaigns, and early cancer screening programs have made a measurable impact.

By contrast, the US has struggled to implement nationwide preventive programs. Even when effective interventions exist — like lifestyle counseling, preventive screenings, and access to affordable medications, barriers in insurance coverage, geography, and affordability keep many Americans from benefiting.

Perhaps the most sobering aspect of the study is that progress is slowing not just in the US but worldwide. Improvements in diagnosis and treatment that once drove sharp declines in chronic disease deaths may be reaching their limits. Unless new strategies are adopted — especially those that reach disadvantaged populations — gains could stall entirely or even reverse.

For the US, where chronic diseases already account for 6 in 10 deaths, the message is clear: without significant investment in prevention and equitable healthcare access, the gap with peer nations will only widen.

Ezzati summed up the findings with a blunt warning, “The risk of dying from chronic diseases in most countries in the world is coming down. But we were doing better before.”

Two people have died, including a university student in meningitis outbreak. University of Kent reported an outbreak of "invasive" meningitis. As per a BBC South East report, 11 people from Cantebury area have also been hospitalized and reported to be seriously ill. Most of these patients are of ages between 18 and 21, and a number of them are students at the university.

The people who have died are also between the age 18 and 21. The spokesperson of University of Kent confirmed that one of the two who died was a student at the university.

The UK Health Security Agency (UKHSA) is contacting the over 30,000 students, staff and their families to inform them of the situation.

Read: What This 19-Year-Old Thought Was 'Freshers' Flu' Actually Turned Out To Be Meningitis

What Is Meningitis?

Meningitis is a serious medical condition that affects the protective membranes covering the brain and spinal cord, the meninges. While fever is not always present, it is usually considered as one of the classic symptoms of meningitis. It is important to know the varied symptoms, causes, and treatments of meningitis for early diagnosis and proper management of the disease.

Meningitis is an infectious illness that brings about inflammation in the meninges. The most common cause of such inflammation is bacterial or viral infections, though other causes are also possible including fungal, parasitic, or non-infectious causes (autoimmune disease, head injury, or brain surgery). Meningitis may be caused by bacterial meningitis, which the Centers for Disease Control and Prevention (CDC) indicates can be so severe and bring about conditions like hearing loss, vision problems, and death if not received on time.

Does Meningitis Always Cause Fever?

Although fever is a common presentation of meningitis, it is not always present. Certain people, particularly those with compromised immune systems, newborns, or the elderly, can get meningitis without significant temperature elevation. In these instances, other signs such as headache, confusion, or stiff neck can be more suggestive symptoms of the disease.

Fever in meningitis is usually caused by the body's immune reaction to the infection, but some factors can affect its occurrence or absence, such as:

• The nature of meningitis (bacterial, viral, fungal, or non-infectious)
• The immune response of the individual
• Pre-existing health conditions
• The course of the disease

What Are The Common Symptoms Of Meningitis?

Meningitis signs may differ based on the reason and severity of infection. Even though fever is a common symptom, it should also be noted for other vital symptoms, which are:

• Severe headache
• Stiff neck
• Photophobia (sensitivity to light)
• Nausea and vomiting
• Confusion or inability to concentrate
• Fatigue or trouble waking up
• Seizures
• Skin rash (in meningococcal meningitis)

Symptoms in infants can be different and also involve excessive crying, irritability, feeding problems, a bulging soft spot (fontanelle) on the head, and unusual lethargy.

The first known case of a more severe strain of Mpox has been discovered in the New York City. This is the Mpox clade 1. Clade 1 strain has a higher mortality rate than Clade 2. According to the latest records, the former strain has a mortality rate of 1-10% compared to Clade 2's 1-4%. Moreover, statistics have shown that Clade 1 infects children more than adults. People with Mpox are considered infectious until all their lesions have crusted over, the scabs have fallen off and a new layer of skin has formed underneath, and all the lesions on the eyes and in the body (in the mouth, throat, eyes, vagina and anus) have healed too.

In the US, since November 2024, a total of 11 cases of this severe strain have been detected.

As per the US Centers for Disease Control and Prevention (CDC), these cases were in people who had recently traveled to areas that have Mpox outbreak, including Central and Eastern Africa. Some cases were also seen in people who may not have traveled, but had links to people who did travel to these areas.

The ray of hope here is that the CDC says the risk of clade 1 Mpox to the general public in the US remains low. A two-dose vaccine for Mpox had been made available since 2022 for people at a higher risk.

What Is Mpox?

MPOX is a viral zoonotic disease, meaning it can be transmitted from animals to humans. It is caused by the monkeypox virus, which belongs to the Orthopoxvirus genus, the same family as the variola virus that causes smallpox. The disease was first identified in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name "monkeypox." The first human case was recorded in 1970 in the Democratic Republic of Congo, during a period when smallpox was being eradicated.

Symptoms of MPOX

MPOX symptoms are similar to those of smallpox but are generally milder. After an incubation period of 5 to 21 days, the disease typically begins with fever, headache, muscle aches, and fatigue. Swelling of the lymph nodes, a distinguishing feature of MPOX, occurs before the appearance of the characteristic rash. The rash usually starts on the face and then spreads to other parts of the body, including the palms of the hands and the soles of the feet. Lesions progress through stages—from macules to papules, vesicles, pustules, and finally scabs—before falling off.

While the disease is usually self-limiting, lasting 2 to 4 weeks, severe cases can occur, especially in children, pregnant women, and immunocompromised individuals. Complications can include secondary bacterial infections, respiratory distress, and, in rare cases, death.

Read: Clade 1 Mpox Virus Detected in US Wastewater; How High Is the Risk of Catching The Virus?

Causes of MPOX: Transmission and Spread

MPOX is primarily transmitted through direct contact with the blood, bodily fluids, or skin lesions of infected animals, including rodents and primates. Human-to-human transmission can occur through close contact with respiratory secretions, skin lesions of an infected person, or recently contaminated objects. It can also be transmitted through respiratory droplets in prolonged face-to-face contact.

The recent global outbreaks have highlighted the possibility of transmission through close contact during sexual activities, although MPOX is not considered a sexually transmitted infection in the traditional sense. The virus can enter the body through broken skin, the respiratory tract, or the mucous membranes of the eyes, nose, or mouth.

Prevention of MPOX

Given the current global emergency, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have issued guidelines for preventing MPOX transmission. Key recommendations include:

• Avoiding contact with animals that could harbor the virus, particularly in regions where MPOX is endemic.
• Practicing good hygiene by washing hands frequently with soap and water or using alcohol-based hand sanitizer.
• Using personal protective equipment (PPE), such as masks, gloves, and gowns, when caring for infected individuals.
• Isolating infected individuals from others who are at risk of contracting the virus.
• Vaccination, where available, is also an effective preventive measure. The smallpox vaccine has been shown to provide some protection against MPOX, and newer vaccines specifically designed for MPOX are being developed and deployed.

Japan has been granted the world's-first approval for two stem cell–based regenerative therapies, one for Parkinson’s disease and one for severe heart failure.

Stem cells are unspecialized foundational cells with the unique ability to self-renew and differentiate into various specialized cell types, such as muscle, blood or brain cells. They are essential for tissue repair, regeneration, and development, acting as an internal repair system.

Stem cell therapy, or regenerative medicine, uses stem cells or their derivatives to repair, replace, or regenerate diseased, dysfunctional, or injured tissue. It involves guiding stem cells to become specialized cells (heart muscle, nerve, or blood cells) to treat conditions like blood cancers, orthopaedic injuries, and neurodegenerative diseases.

Based on the Japanese approval, the Parkinson’s stem cell therapy treatment uses induced pluripotent stem cells (iPSCs) that are converted into dopamine-producing neurons and transplanted into the brain to replace cells lost during the disease.

Moreover, the heart failure therapy involves placing sheets of stem cell–derived heart muscle cells onto the heart, which may help restore cardiac function by promoting tissue repair and new blood vessel growth.

Both therapies received conditional approval, meaning they can be used clinically while researchers continue to collect additional safety and effectiveness data from patients.

What Is Parkinson's Disease?

Parkinson's disease is a progressive, neurodegenerative movement disorder caused by the loss of dopamine-producing brain cells, primarily affecting people over 60. Apart from motor loss, the disease also causes cognitive decline, depression, anxiety and swallowing problems.

The first symptom may be a barely noticeable tremor in just one hand or sometimes a foot or the jaw. Over time, swinging your arms may become difficult and your speech may become soft or slurred. The disorder also causes stiffness, slowing of movement and trouble with balance that raises the risk of falls.

Lifestyle Changes Can Prevent Parkinson's Disease

While Parkinson’s disease cannot be entirely prevented, experts suggest several lifestyle modifications that may reduce the risk. Dr Himanshu Champaneri, Senior Consultant in the Department of Neurosciences and Neurosurgery at Marengo Asia Hospitals in Gurugram told India Today that physical activity could aid in maintaining brain health. He recommends engaging in at least 150 minutes of moderate-to-intense exercise per week, including walking, running, swimming, and dancing.

Meanwhile, other experts have suggested that certain types of Parkinson's disease such as vascular Parkinsonism, are linked to the hardening of brain blood vessels. To mitigate this risk, she advises regular exercise, a low-fat diet, and monitoring blood pressure, sugar, and cholesterol levels. Additionally, industrial pollution is associated with an increased incidence of Parkinson's.

She suggests spending time in natural environments away from industrial pollutants to help lower the risk.